Avadel Pharmaceuticals PLC
NASDAQ:AVDL

Watchlist Manager
Avadel Pharmaceuticals PLC Logo
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Watchlist
Price: 8.01 USD -1.35% Market Closed
Market Cap: 774m USD

Intrinsic Value

The intrinsic value of one AVDL stock under the Base Case scenario is 13.43 USD. Compared to the current market price of 8.01 USD, Avadel Pharmaceuticals PLC is Undervalued by 40%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AVDL Intrinsic Value
13.43 USD
Undervaluation 40%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Avadel Pharmaceuticals PLC

AVDL
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for AVDL cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Avadel Pharmaceuticals PLC
NASDAQ:AVDL
IE
Pharmaceuticals
Market Cap
773.1m USD
IPO
Jan 16, 1952
IE
Pharmaceuticals
Market Cap
773.1m USD
IPO
Jan 16, 1952
Price
$false
EPS
$false
Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about AVDL?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Avadel Pharmaceuticals PLC
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Avadel Pharmaceuticals PLC

Current Assets 134.2m
Cash & Short-Term Investments 73.8m
Receivables 34.1m
Other Current Assets 26.3m
Non-Current Assets 30m
PP&E 2.2m
Intangibles 16.8m
Other Non-Current Assets 11m
Efficiency

Free Cash Flow Analysis
Avadel Pharmaceuticals PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Avadel Pharmaceuticals PLC

Revenue
169.1m USD
Cost of Revenue
-15.3m USD
Gross Profit
153.8m USD
Operating Expenses
-196.2m USD
Operating Income
-42.4m USD
Other Expenses
-6.4m USD
Net Income
-48.8m USD
Fundamental Scores

AVDL Profitability Score
Profitability Due Diligence

Avadel Pharmaceuticals PLC's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
ROIC is Increasing
29/100
Profitability
Score

Avadel Pharmaceuticals PLC's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

AVDL Solvency Score
Solvency Due Diligence

Avadel Pharmaceuticals PLC's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
42/100
Solvency
Score

Avadel Pharmaceuticals PLC's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AVDL Price Targets Summary
Avadel Pharmaceuticals PLC

Wall Street analysts forecast AVDL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AVDL is 18.05 USD with a low forecast of 13.13 USD and a high forecast of 23.1 USD.

Lowest
Price Target
13.13 USD
64% Upside
Average
Price Target
18.05 USD
125% Upside
Highest
Price Target
23.1 USD
188% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Avadel Pharmaceuticals PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for AVDL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

AVDL Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one AVDL stock?

The intrinsic value of one AVDL stock under the Base Case scenario is 13.43 USD.

Is AVDL stock undervalued or overvalued?

Compared to the current market price of 8.01 USD, Avadel Pharmaceuticals PLC is Undervalued by 40%.

Back to Top